Nervonik Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $52.5M

  • Investors
  • 16

Nervonik General Information

Description

Developer of a neuro-modulation device designed for therapeutic applications. The company utilizes proprietary wireless power delivery, miniaturized implantable leads, and integrated sensing circuits to provide real-time physiological feedback and closed-loop stimulation parameters tailored to individual patient needs, enabling patients to access an opioid-free, minimally invasive alternative to traditional spinal cord stimulators and pharmaceutical interventions for long-term neuropathic relief.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11965 Gorham Avenue
  • Suite 301
  • Los Angeles, CA 90049
  • United States
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 11965 Gorham Avenue
  • Suite 301
  • Los Angeles, CA 90049
  • United States

Nervonik Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nervonik Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 20-Apr-2026 $52.5M Completed Generating Revenue
4. Later Stage VC (Series A) 27-Feb-2025 Completed Generating Revenue
3. Early Stage VC (Series A) 05-Mar-2024 Completed Startup
2. Early Stage VC (Series A) 01-Aug-2021 $1.6M $1.6M Completed Startup
1. University Spin-Out 23-Oct-2020 Completed Startup
To view Nervonik’s complete valuation and funding history, request access »

Nervonik Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A-4
Series A-3
Series A-2 70,279 $0.000010 $0.06 $0.75 $0.75 1x $0.75 0.31%
Series A-1 3,343,472 $0.000010 $0.31 $3.89 $3.89 1x $3.89 14.67%
To view Nervonik’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nervonik Patents

Nervonik Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026231643-A1 Connector assemblies for medical devices Pending 01-May-2025
EP-4655053-A1 Systems and methods for external control of power transmission to, and stimulation therapy by, an implanted neuromodulation device Pending 24-Jan-2023
US-20260115474-A1 Systems and methods for external control of power transmission to, and stimulation therapy by, an implanted neuromodulation device Pending 24-Jan-2023
WO-2024158670-A1 Systems and methods for external control of power transmission to, and stimulation therapy by, an implanted neuromodulation device Inactive 24-Jan-2023
WO-2024158670-A9 Systems and methods for external control of power transmission to, and stimulation therapy by, an implanted neuromodulation device Inactive 24-Jan-2023 A61N1/0551
To view Nervonik’s complete patent history, request access »

Nervonik Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nervonik Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amzak Health Venture Capital Minority
Angel (individual) Minority
Elevage Medical Technologies Growth/Expansion Minority
Lumira Ventures Venture Capital Minority
Correlation Ventures Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Nervonik FAQs

  • When was Nervonik founded?

    Nervonik was founded in 2020.

  • Where is Nervonik headquartered?

    Nervonik is headquartered in Los Angeles, CA.

  • What is the size of Nervonik?

    Nervonik has 12 total employees.

  • What industry is Nervonik in?

    Nervonik’s primary industry is Therapeutic Devices.

  • Is Nervonik a private or public company?

    Nervonik is a Private company.

  • What is the current valuation of Nervonik?

    The current valuation of Nervonik is .

  • What is Nervonik’s current revenue?

    The current revenue for Nervonik is .

  • How much funding has Nervonik raised over time?

    Nervonik has raised $70M.

  • Who are Nervonik’s investors?

    Amzak Health, , Elevage Medical Technologies, Lumira Ventures, and Correlation Ventures are 5 of 16 investors who have invested in Nervonik.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process